A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer.

Takuma KatoYoichiro TohiTomoko HondaIori MatsudaYu OsakiHirohito NaitoYuki MatsuokaHomare OkazoeRikiya Taoka Hiroyuki TsunemoriNobufumi UedaMikio Sugimoto

Published in: International journal of urology : official journal of the Japanese Urological Association (2022)

Approximately 40% of urologists proposed AS for intermediate-risk cases, confirming that AS for intermediate-risk patients is being considered in Japan.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
chronic kidney disease
cross sectional
patient reported
quality improvement
patient reported outcomes